Crossmark

Predictive value of P300 event-related potential component in early cognitive impairment in patients with uncomplicated newly diagnosed hepatitis C virus

Crossref DOI link: https://doi.org/10.1186/s41983-022-00450-4

Published Online: 2022-01-29

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Esmael, Ahmed https://orcid.org/0000-0003-2879-7392
Belal, Tamer

Amer, Ibrahim F.

Samra, Eslam

Elmongui, Azza

Shawki, Saad
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct04389268 at ClinicalTrials.gov

Documents that mention this clinical trial

Predictive value of P300 event-related potential component in early cognitive impairment in patients with uncomplicated newly diagnosed hepatitis C virus
https://doi.org/10.1186/s41983-022-00450-4
License Information

Text and Data Mining valid from 2022-01-29

Version of Record valid from 2022-01-29
More Information

Article History

Received: 6 September 2021

Accepted: 14 January 2022

First Online: 29 January 2022

Declarations

:

: All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration. Informed written consent was obtained from all individual participants included in the study. This study was approved by Mansoura Faculty of Medicine Institutional Research Board ("MFM-IRB").

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below